Skyrizi 00074-7040-02
Generic: Risankizumab-Rzaa
- Manufacturer
- Abbvie Inc.
- Dosage Form
- Kit
- Product Type
- Human Prescription Drug
- Marketing Start
- March 4, 2024
- Listing Expires
- December 31, 2027
- Application
- BLA761105
Need to source Skyrizi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Drug Class
Interleukin-23 Antagonist [EPC]
Selected Package
00074-7040-02Selected2 CARTON in 1 CARTON (0074-7040-02) / 1 KIT in 1 CARTON * 1 mL in 1 SYRINGE, GLASS (0074-7032-01)